An Overview of Psychedelic-Assisted Therapy
EMBARK Psychedelic Therapy for Depression April 23, 2024 DOI: 10.1093/9780197762622.003.0002 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Randomized Peer reviewed |
|---|---|
| Interventions | Psychedelic-assisted therapy EMBARK model |
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychedelic medicine Entheogenic therapy Mental health Mental wellness Behavioral health Psychiatric care Therapeutic models Treatment frameworks Clinical approaches Intervention models Medical innovation Healthcare innovation Novel therapies Clinical advancements |
| Key points | Argues that the EMBARK model offers a transdiagnostic and trans-drug framework adaptable to various indications and psychedelic medicines, and that conventional PAT histories have missed critical harms and marginalized perspectives. |
Abstract
AbstractChapter 1 introduces the concept of psychedelic-assisted therapy (PAT) and the EMBARK psychedelic therapy model, a new approach to PAT and psychological support. The chapter serves as an orientation to the book, outlining its structure and intended audiences. It discusses the growing interest in psychedelic medicines for treating mental health disorders, particularly depression. The authors provide a conventional history of PAT research and criticize this history for missing critical histories of harm and the stories of marginalized groups. The EMBARK model is introduced, offering a transdiagnostic and trans-drug approach adaptable to various indications and psychedelic medicines. The authors review common PAT elements, including the preparation, medicine, and integration phases of treatment; therapist dyads; set and setting; and the importance of providing a therapeutic container. The chapter also characterizes the emerging evidence base for EMBARK, mentioning ongoing randomized clinical trials piloting the EMBARK model and the free EMBARK Open Access training program.
Comparable studies
Other theoretical and historical papers on psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders. | 2024 | Theoretical or philosophical paper | |
| Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance | 2020 | Theoretical or philosophical paper | |
| Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy | 2018 | Theoretical or philosophical paper | |
| Ethical and legal issues in psychedelic harm reduction and integration therapy | 2021 | Theoretical or philosophical paper | |
| Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. | 2022 | Theoretical or philosophical paper |
Citations in the library
Cites 216
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
and 211 more in the library